Josef Jampilek completed his Ph.D. degree in Medicinal Chemistry at the Faculty of Pharmacy of the Charles University (Czech Republic) in 2004. In 2004-2011, he worked in expert and managerial posts in the R&D Division of the pharmaceutical company Zentiva (Czech Republic). Prof. Jampilek deepened his professional knowledge at the Medicinal Chemistry Institute of the Heidelberg University (Germany) and at multiple specialized courses. In 2009, he became an Associate Professor of Medicinal Chemistry at the Faculty of Pharmacy of the University of Veterinary and Pharmaceutical Sciences Brno (Czech Republic). In 2017, he became a Professor of Medicinal Chemistry at the Faculty of Pharmacy, Comenius University (Slovakia). He is an author/co-author of 30 patents, more than 140 peer-reviewed scientific publications, 7 university textbooks and 15 chapters in monographs. He also received several awards for his scientific results, e.g., from Aventis, Elsevier, Willey and Sanofi. The research interests of Prof. Jampilek include design, synthesis and structure-activity relationships of heterocyclic compounds as anti-invasive agents and photosynthesis inhibitors. He is also interested in ADME and drug bioavailability.